StonvexLoading…
StonvexStonvexStonvexCore line items from AMGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $36.75B | $33.42B | $28.19B | $26.32B |
Operating Income | $9.08B | $7.26B | $7.90B | $9.57B |
Net Income | $7.71B | $4.09B | $6.72B | $6.55B |
EPS (Diluted) | $14.23 | $7.56 | $12.49 | $12.11 |
Total Assets | $90.59B | $91.84B | $97.15B | $65.12B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.13B | $11.97B | $10.94B | $7.63B |
Free Cash Flow OCF − CapEx | $8.10B | $10.39B | $7.36B | $8.79B |
Shares Outstanding | 538.80M | 536.90M | 535.40M | 534.00M |